News Quantified

INNV – innovage holding corp. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

InnovAge Holding Corp. (NASDAQ: INNV) had its "underweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $5.00 price target on the stock.

InnovAge offers all-inclusive care center that nurtures passions for seniors in Philadelphia [CBS News]

InnovAge Celebrates 35 Years of Transforming Senior Care [Yahoo! Finance]

InnovAge Celebrates 35 Years of Transforming Senior Care

InnovAge Holding Corp (INNV) Q1 2025 Earnings Call Highlights: Revenue Surge and Operational ... [Yahoo! Finance]

3.8%

IN-LINE

-6.5%

IN-LINE

0.0%

IN-LINE

-3.9%

IN-LINE

JPMorgan Chase & Co.

Form 8-K InnovAge Holding Corp. For: Dec 05

Form 4 InnovAge Holding Corp. For: Dec 01 Filed by: BLAIR PATRICK T

Form SC 13G/A InnovAge Holding Corp. Filed by: TCO GROUP HOLDINGS, L.P.

Form 4 InnovAge Holding Corp. For: Nov 06 Filed by: DAMATO NICOLE

Form 10-Q InnovAge Holding Corp. For: Sep 30

Top News Gainers

5/31 Form 8-K INNOVUS PHARMACEUTICALS, For: May 28 14.5%

1/15 Form SC 13G INNOVUS PHARMACEUTICALS, Filed by: LGH Investments, LLC 11.6%

8/9 Innovus Pharmaceuticals to Release Second Quarter 2019 Financial Results and Provide Corporate Update on Tuesday, August 13, 2019 11.6%

9/23 Form 425 INNOVUS PHARMACEUTICALS, Filed by: AYTU BIOSCIENCE, INC 8.4%

6/4 Innovus Pharma Expands its OTC Drug Pipeline with the Addition of OmepraCare™ (a Competitor of Prilosec® OTC) 7.3%

2/14 Form 8-K INNOVUS PHARMACEUTICALS, For: Feb 13 6.0%

6/19 Innovus Pharmaceuticals Announces Progress in Fulfilling the Regulatory and Manufacturing Steps to Receive Market Authorization for FlutiCare® in Canada 5.6%

9/13 Form 425 INNOVUS PHARMACEUTICALS, Filed by: INNOVUS PHARMACEUTICALS, INC. 3.8%

5/8 Innovus Pharma Announces a Second Partnered United States OTC ANDA for Minoxidil 5% Foam for Men and Women 3.4%

5/28 Following Its Recent Approval from Health Canada for the Relief of Neuropathy Pain, Innovus Pharma Announces Receipt of Notification to Commercialize Diabasens® in the European Union 3.4%

Top News Decliners

5/15 Innovus Pharma Reports Quarterly Revenue for the First Quarter 2019 of $5.4 Million, a 18.0% Increase from Comparable Quarter in the Prior Year -15.1%

8/13 Innovus Pharma Reports Quarterly Revenue for the Second Quarter 2019 of $6.8 million, a 27.7% Increase from Prior Quarter -10.1%

6/10 Form S-8 INNOVUS PHARMACEUTICALS, -8.1%

9/18 Form 3 INNOVUS PHARMACEUTICALS, For: Sep 13 Filed by: Armistice Capital Master Fund Ltd. -7.9%

9/17 Innovus Pharmaceuticals Inc (OTCMKTS: INNV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock. -6.9%

11/15 Innovus Pharmaceuticals Inc (OTCMKTS: INNV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock. -6.1%

5/6 Innovus Pharmaceuticals Reports Preliminary Q1 2019 Sales Revenue of Approximately $5.4 million -5.7%

5/13 Innovus Pharma’s Partner Lavasta Receives Approval from Algeria to Market and Sell Zestra® and Zestra Glide® in that Country -2.2%

7/22 Form 8-K INNOVUS PHARMACEUTICALS, For: Jul 22 -1.9%

6/6 Innovus Pharmaceuticals Receives Notification to Market and Sell CarvaNum® for Muscle Recovery in the European Union -1.5%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day